Alnylam Pharmaceuticals, Inc.
Xanthine dehydrogenase (XDH) IRNA compositions and methods of use thereof

Abstract:

The present invention relates to RNAi agents, e.g., double stranded RNAi agents, targeting a xanthine dehydrogenase (XDH) gene, and methods of using such double stranded RNAi agents to inhibit expression of an XDH gene and methods of treating subjects having an XDH-associated disease.